Toronto, Canada
Apotex Inc. is a prominent, Canadian-based global health company that has been leading the way in producing high-quality, affordable medicines for patients worldwide since 1974. With a workforce of nearly 8,000 individuals across the globe, the company is actively engaged in manufacturing, R&D, and commercial operations. Its extensive reach spans across 100 countries and territories, with a strong presence in Canada, the US, Mexico, and India.
Through its strategic approach of vertical integration, Apotex encompasses diverse divisions and affiliates, including Apotex Inc., focusing on generics; Apobiologix, dedicated to biosimilar development; Apotex Consumer Products, specializing in brand name products; and Global Active Pharmaceutical Ingredients (GAPI), engaged in the manufacturing of active pharmaceutical ingredients (API) for Apotex and third parties.
Despite the lack of specific information on the last investment and investors, Apotex Inc. is positioned as a significant player in the manufacturing and pharmaceutical industries, with its headquarters located in Canada.
Alivira Animal Health Limited
